Zusammenfassung
Nach dem Mammakarzinom ist das Zervixkarzinom weltweit die zweithäufigste, tumorbedingte Todesursache bei Frauen. In der westlichen Welt sterben jährlich etwa 40.000 Frauen am fortgeschrittenen Zervixkarzinom; in Entwicklungsländern sind es sechsmal so viele. Diese schlechte Prognose bei einer grundsätzlich vermeidbaren Krebserkrankung kann durch die Frühdiagnose mittels Papanicolaou-Screening entscheidend verbessert werden.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Rose PG, Bundy BN, Watkins EB, et al: Concurrent cisplatin- based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340: 1144–1153, 1999.
Peters WA III, Liu PY, Barret RJ Jr, et al: Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after redical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18: 1606–1613, 2000.
Keys HM, Bundy BN, Stehman FB, et al: Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340:1154–1161, 1999.
Morris M, Eifel PJ, Lu J, et al: Pelvic irradiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer: N Engl J Med 340:1137–1143, 1999.
Eifel PJ, Winter K, Morris M, et al: Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of Radiation Therapy Oncology Group trial (RTOG) 90-01. J Clin Oncol 22:872–880, 2004.
Yessaian A, Magistris A, Burger RA, et al: Radical hysterectomy followed by tailored postoperative therapy in the treatment of stage IB2 cervical cancer: Feasibility and indications for adjuvant therapy. Gynecol Oncol 94:61–66, 2004.
Bradley JM, Krishnansu ST, Wui-Jin K, et al: Multimodality therapy for locally advanced cervical carcinoma: State of the art and future directions. J Clin Oncol 25:2952–2965, 2007.
Monk B J, Tewari KS, Wui-Jin Koh: Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions. J Clin Oncol 25: 2952–2965, 2007.
Petereit DG, Pearcey R: Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: Is there an optimal fractionation schedule? Int J Radiat Oncol Biol Phys 43:359–366, 1999.
Mai J, Erickson B, Rownd J, et al: Comparison of four different dose specification methods for high-dose-rate Intracavitary radiation for treatment of cervical cancer. Int J Radiat Oncol Biol Phys 51:1131–1141, 2001.
Vistad I, Fossa SD, Dahl AA: A critical review of patientrated quality of life studies of long-term survivors of cervical cancer: Gynecol Oncol 102:563–573, 2006.
Wenzel L, DeAlba I, Habal R, et al: Quality of life in longterm cervical cancer survivors. Gynecol Oncol 97:310–317, 2005.
Stephens FO, Why use regional chemotherapy? Principles ande Pharmacokinetics. Reg Cancer Treat 1: 4–10, 1988.
Villena-Heinsen C, Mink D, Lung-Kurt S, et al: Preoperative intraarterial chemotherapy for bulky cervical carcinoma in stage Ib – IIb. Reg Cancer Treat 1:17–21, 1994.
Scarabelli C, Zarrelli A, Gallo A, et al: Pelvic recurrences in cervical cancer : multimodal treatment with sequential intra-arterial chemotherapy and surgery. Reg Cancer Treat 1:12–16, 1994.
de Dycker RP: Pelvic arterial chemotherapy in cervical cancer. Reg Cancer Treat 7:43–46, 1994.
Aigner KR, Gailhofer S: 6 years disease free survival after isolated hypoxic pelvic perfusion with chemofiltration for advanced cervical carcinoma. J Nucl Med Radiat Ther 2012 S2:007. DOI:1.S2–007
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Aigner, K.R., Jansa, J. (2013). Induktionschemotherapie bei Tumoren des Beckens – das Zervixkarzinom. In: Aigner, K.R., Stephens, F.O., Vogl, T.J., Padberg, W. (eds) Regionale Therapie maligner Tumoren. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-35014-6_21
Download citation
DOI: https://doi.org/10.1007/978-3-642-35014-6_21
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-35013-9
Online ISBN: 978-3-642-35014-6
eBook Packages: Medicine (German Language)